205.452.01004 Boehringer Ingelheim Investigational Site

Rapid City, South Dakota

We've found

2 trials

at this facility

Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

Status: Enrolling
Updated: 9/18/2012

from

Rapid City, SD

Afatinib Expanded Access Program

Status: Enrolling
Updated: 11/29/2016

from

Rapid City, SD

Use our guide to learn which trials are right for you!